Direct ITR-to-ITR Nanopore Sequencing of AAV Vector Genomes

被引:11
|
作者
Namkung, Suk [1 ]
Tran, Ngoc Tam [1 ,2 ]
Manokaran, Sangeetha [1 ]
He, Ran [1 ]
Su, Qin [1 ]
Xie, Jun [1 ,2 ]
Gao, Guangping [1 ,2 ,3 ]
Tai, Phillip W. L. [1 ,2 ,3 ,4 ]
机构
[1] UMass, Chan Med Sch, Horae Gene Therapy Ctr, Worcester, MA USA
[2] UMass, Chan Med Sch, Dept Microbiol & Physiol Syst, Worcester, MA USA
[3] UMass, Chan Med Sch, Li Weibo Inst Rare Dis Res, Worcester, MA USA
[4] UMass, Chan Med Sch, Horae Gene Therapy Ctr, Worcester, MA 01605 USA
关键词
adeno-associated virus; nanopore; vector heterogeneity; inverted terminal repeat; BINDING; REP68;
D O I
10.1089/hum.2022.143
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recombinant adeno-associated viruses (rAAVs) are currently the most prominently investigated vector platform for human gene therapy. The rAAV capsid serves as a potent and efficient vehicle for delivering genetic payloads into the host cell, while the vector genome determines the function and effectiveness of these biotherapies. However, current production schemes yield vectors that may consist of heterogeneous populations, compromising their potencies. The development of next-generation sequencing methods within the past few years have helped investigators profile the diversity and relative abundances of heterogenous species in vector preparations. Specifically, long-read sequencing methods, like single molecule real-time (SMRT) sequencing, have been used to uncover truncations, chimeric genomes, and inverted terminal repeat (ITR) mutations in vectors. Unfortunately, these sequencing platforms may be inaccessible to investigators with limited resources, require large amounts of input material, or may require long wait times for sequencing and analyses. Recent advances with nanopore sequencing have helped to bridge the gap for quick and relatively inexpensive long-read sequencing needs. However, their limitations and sample biases are not well-defined for sequencing rAAV. In this study, we explored the capacity for nanopore sequencing to directly interrogate rAAV content to obtain full-length resolution of encapsidated genomes. We found that the nanopore platform can cover the entirety of rAAV genomes from ITR to ITR without the need for pre-fragmentation. However, the accuracy for base calling was low, resulting in a high degree of miscalled bases and false indels. These false indels led to read-length compression; thus, assessing heterogeneity based on read length is not advisable with current nanopore technologies. Nonetheless, nanopore sequencing was able to correctly identify truncation hotspots in single-strand and self-complementary vectors similar to SMRT sequencing. In summary, nanopore sequencing can serve as a rapid and low-cost alternative for proofing AAV vectors.
引用
收藏
页码:1187 / 1196
页数:10
相关论文
共 50 条
  • [1] Direct ITR-To-ITR Nanopore Sequencing of Plasmid and Vector Preparations and Their Implications for In Vivo Gene-Editing Vector Performance
    Namkung, Suk
    Ibraheim, Raed
    Tran, Ngoc Tam
    Sontheimer, Erik
    Gao, Guangping
    Tai, Phillip
    MOLECULAR THERAPY, 2022, 30 (04) : 22 - 23
  • [2] Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR
    D'Costa, Susan
    Blouin, Veronique
    Broucque, Frederic
    Penaud-Budloo, Magalie
    Francois, Achille
    Perez, Irene C.
    Le Bec, Christine
    Moullier, Philippe
    Snyder, Richard O.
    Ayuso, Eduard
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 : 16019
  • [3] Impact Assessment of ITR Instability Observed in AAV Plasmids on Vector Productivity and Potency
    Chen, Xingcheng
    Batra, Rashi
    Morgan, Lukas
    Jin, Wen
    Moroski-Erkul, Catherine
    Chinnasamy, Vignesh
    Xia, Siyang
    Kramer, Tal
    Chu, Chia
    Vitelli, Francesca
    MOLECULAR THERAPY, 2024, 32 (04) : 281 - 282
  • [4] Novel AAV ITR Sequencing and AAV Plasmid Preparation Protocols to Advance Research and Therapies Using AAV Vectors
    Zhao, Jian
    Xiao, Ying
    Kotulak, Kristin
    Leung, Conrad
    MOLECULAR THERAPY, 2020, 28 (04) : 435 - 435
  • [5] Influence of defect ITR on the packaging and infectivity of AAV
    Zuo-Wu, Cao
    Yi, Lin
    Long-Qiu, Cheng
    Fei-Yan, Zou
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2008, 35 (02) : 224 - 230
  • [6] Characterization of the AAV ITR Host Protein Interactome
    Brittain, Tyler
    Borsos, Mate
    Gradinaru, Viviana
    MOLECULAR THERAPY, 2023, 31 (04) : 228 - 228
  • [7] A BREAKTHROUGH GLP AAV-ITR SANGER SEQUENCING SOLUTION FOR NEW DRUG DEVELOPMENT
    Louie, E.
    O'Hara, A.
    Geahlen, J.
    Lawrence, J.
    Latif, H.
    Zhou, G.
    CYTOTHERAPY, 2022, 24 (05) : S143 - S143
  • [8] Optimization of AAV Vector Design to Reduce Cross-Packaging and ITR Promoter Activity
    Guggenbiller, Matthew John
    Taylor, Noah
    Harper, Scott Q.
    MOLECULAR THERAPY, 2023, 31 (04) : 664 - 664
  • [9] A Breakthrough GLP AAV-ITR Sanger Sequencing Solution for New Drug Development
    Louie, Elizabeth
    O'Hara, Andrea
    Lawrence, Janet
    Geahlen, Jessica
    Latif, Haythem
    Zhou, Ginger
    MOLECULAR THERAPY, 2022, 30 (04) : 78 - 78
  • [10] AAV Genome Topology Decides ITR Secondary Structure
    Wilmott, Patrick
    Lisowski, Leszek
    BIOESSAYS, 2025,